NHSL3 and lung adenocarcinoma: Here, we found that KIAA1522 may modulating NFκB activity via TNFR2, a TNFα receptor transmitting only anti-apoptotic signals [41], that is in concordance with the roles of KIAA1522 in lung adenocarcinomas.